Terrence Higgins Trust uses cookies to improve your experience of our websites. For more information or to change the use of cookies, please click here.

Accept and Close

emtricitabine (Emtriva)


Generic name: emtricitabine, sometimes also called FTC.

Brand names: Emtriva

Class: Individual NRTIs (nukes)


Very common (affecting at least 10 in every 100 people): Nausea, diarrhoea, headache, raised creatine kinase levels in the blood which can cause muscle pain and weakness.

Common (affecting up to 10 in every 100 people): skin darkening especially in children, difficulty sleeping, abnormal dreams, dizziness, vomiting, stomach pain, rash, pain, weakness, low white blood cell count, increased triglycerides, bile or sugar in the blood, liver problems, pancreas problems.

Uncommon (affecting up to 1 in every 100 people): Anaemia, swelling of the face, lips, tongue or throat.


200mg capsule.

Take 200mg once a day.

An oral solution (at a concentration of 10mg/ml) is available for those with difficulty swallowing the capsules or those with kidney problems.


Take with or without food.

*Last reviewed on 19/12/2016 Next review: 19/12/2019

Any questions? Email feedback@tht.org.uk Information included on this website was correct at the time of publication.

Data and image supplied by NAM.

Further information on this drug from NAM